These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25730009)

  • 21. Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients.
    Ashikaga E; Honda H; Suzuki H; Hosaka N; Hirai Y; Sanada D; Nakamura M; Nagai H; Matsumoto K; Kato N; Mukai M; Watanabe M; Takahashi K; Shishido K; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):315-22. PubMed ID: 20609185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low serm Fibroblast Growth Factor-21 levels is not associated with Carotid intima-media thickness in acromegaly patients.
    Uygur MM; Dereli Yazıcı D; Gogas Yavuz D
    J Endocrinol Invest; 2022 Jul; 45(7):1405-1412. PubMed ID: 35334074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum albumin and von Willebrand factor: possible markers for early detection of vascular damage in children undergoing peritoneal dialysis.
    Cetın N; Sav NM; Karabel D; Yildirim A; Yıldız B
    Clin Invest Med; 2016 Sep; 39(4):E111-9. PubMed ID: 27619398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FGF-23 in patients with end-stage renal disease on hemodialysis.
    Imanishi Y; Inaba M; Nakatsuka K; Nagasue K; Okuno S; Yoshihara A; Miura M; Miyauchi A; Kobayashi K; Miki T; Shoji T; Ishimura E; Nishizawa Y
    Kidney Int; 2004 May; 65(5):1943-6. PubMed ID: 15086938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis.
    Wesseling-Perry K; Pereira RC; Wang H; Elashoff RM; Sahney S; Gales B; Jüppner H; Salusky IB
    J Clin Endocrinol Metab; 2009 Feb; 94(2):511-7. PubMed ID: 19050056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fibroblast growth factor 23 and a novel high-sensitivity troponin I: Early markers and alternative ways of damaging the heart in chronic kidney disease].
    Dzgoeva FU; Sopoev MY; Gatagonova TM; Bestaeva TL; Khamitsaeva OV
    Ter Arkh; 2015; 87(6):68-74. PubMed ID: 26281199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients.
    Viaene L; Bammens B; Meijers BK; Vanrenterghem Y; Vanderschueren D; Evenepoel P
    Nephrol Dial Transplant; 2012 May; 27(5):2017-22. PubMed ID: 22025115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.
    Seiler S; Cremers B; Rebling NM; Hornof F; Jeken J; Kersting S; Steimle C; Ege P; Fehrenz M; Rogacev KS; Scheller B; Böhm M; Fliser D; Heine GH
    Eur Heart J; 2011 Nov; 32(21):2688-96. PubMed ID: 21733911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationships between serum sTWEAK, FGF-23 levels, and carotid atherosclerosis in renal transplant patients.
    Gungor O; Kismali E; Sisman AR; Kircelli F; Carrero JJ; Tatar E; Asci G; Toz H
    Ren Fail; 2013; 35(1):77-81. PubMed ID: 23101788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lower serum fibroblast growth factor-23 levels may suggest malnutrition in maintenance haemodialysis patients.
    Mizuiri S; Nishizawa Y; Yamashita K; Ono K; Oda M; Usui K; Shigemoto K
    Nephrology (Carlton); 2014 Sep; 19(9):568-73. PubMed ID: 24947687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
    Gutiérrez OM; Januzzi JL; Isakova T; Laliberte K; Smith K; Collerone G; Sarwar A; Hoffmann U; Coglianese E; Christenson R; Wang TJ; deFilippi C; Wolf M
    Circulation; 2009 May; 119(19):2545-52. PubMed ID: 19414634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications.
    González E; Díez JJ; Bajo MA; del Peso G; Grande C; Rodríguez O; Díaz-Almirón M; Iglesias P; Selgas R
    PLoS One; 2016; 11(3):e0151698. PubMed ID: 26986485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of fibroblast growth factor 23 in the development of cardiovascular diseases in patients with end-stage renal failure on programmed hemodialysis].
    Dzgoeva FU; Sopoev MY; Bestaeva TL; Khamitsaeva OV; Ktsoeva FA; Sageeva RO
    Ter Arkh; 2016; 88(12):51-56. PubMed ID: 28139560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.
    Sato T; Tominaga Y; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Uchida K; Nakanishi S; Kazama JJ; Gejyo F; Yamashita T; Fukagawa M
    Am J Kidney Dis; 2004 Sep; 44(3):481-7. PubMed ID: 15332221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors.
    Pello AM; Cristóbal C; Tarín N; Huelmos A; Aceña Á; Carda R; González-Casaus ML; Alonso J; Lorenzo Ó; Blanco-Colio L; Martín-Ventura JL; Franco Peláez JA; Mahíllo-Fernández I; Farré J; López-Bescós L; Egido J; Tuñón J
    J Cardiol; 2015 Jul; 66(1):22-7. PubMed ID: 25533425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast growth factor-23 levels are associated with vascular calcifications in peritoneal dialysis patients.
    Asicioglu E; Kahveci A; Arikan H; Koc M; Tuglular S; Ozener CI
    Nephron Clin Pract; 2013; 124(1-2):89-93. PubMed ID: 24157489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients.
    Bellasi A; Raggi P; Rossi R; Rochira V; Stentarelli C; Zona S; Lattanzi A; Carli F; Mussini C; Guaraldi G
    Atherosclerosis; 2014 Dec; 237(2):618-22. PubMed ID: 25463096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spatial QRS-T angle in peritoneal dialysis patients: association with carotid artery atherosclerosis, coronary artery calcification and troponin T.
    Jaroszynski A; Czekajska-Chechab E; Drelich-Zbroja A; Zapolski T; Ksiazek A
    Nephrol Dial Transplant; 2009 Mar; 24(3):1003-8. PubMed ID: 18978067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis.
    Han SH; Choi SH; Cho BJ; Lee Y; Lim S; Park YJ; Moon MK; Lee HK; Kang SW; Han DS; Kim YB; Jang HC; Park KS
    Metabolism; 2010 Nov; 59(11):1656-62. PubMed ID: 20423749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients.
    Inaba M; Okuno S; Imanishi Y; Yamada S; Shioi A; Yamakawa T; Ishimura E; Nishizawa Y
    Osteoporos Int; 2006 Oct; 17(10):1506-13. PubMed ID: 16896512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.